Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Nuclear mTORC1 and the TerminaTOR Strategy
2026-08-12
The reference study introduces TerminaTOR, a genetically encoded inhibitor that can be directed to distinct subcellular pools of mTORC1. By comparing lysosomal and nuclear targeting, the authors show that nuclear mTORC1 has a specialized role in regulating transcription of CCAAT motif-containing genes, separating this function from canonical lysosomal signaling and autophagy control.
-
HOXC8, Caspase-1, and Pyroptosis in NSCLC
2026-08-12
The reference study shows that HOXC8 supports non-small cell lung carcinoma by repressing caspase-1 transcription through HDAC1/2 recruitment, thereby limiting pyroptotic cell death. Its combination of pharmacologic, molecular, and in vivo experiments identifies an ASC-independent caspase-1 pathway and suggests a mechanistic framework for studying tumor-associated inflammation.
-
AICAR Phosphate: Context-Aware AMPK Assays
2026-08-11
AICAR phosphate (Acadesine) is more than an AMPK activator: it is a context-sensitive perturbation tool for separating metabolic signaling from apoptosis. This guide connects B-CLL cell-death assays with hypoxia-driven choroid plexus biology and provides practical strategies for interpreting pathway, mitochondrial, and viability readouts.
-
Clozapine N-oxide: Mapping Cortical State
2026-08-11
Clozapine N-oxide (CNO) can do more than activate DREADDs: it can help separate cell-type-specific cortical activity from behavioral outcomes. This article translates recent chronic migraine findings into practical chemogenetic assay decisions for neuronal activity modulation.
-
Lipo3K Transfection Reagent for Kidney Assays
2026-08-10
Build low-toxicity DNA, siRNA, and co-transfection workflows for kidney organoids, nephron progenitors, and other challenging models. The approach connects DDIT4-focused microplastic toxicology with practical delivery, timing, controls, and troubleshooting decisions.
-
Cyclic Pifithrin-α: A Translational p53 Lens
2026-08-09
A mechanistic and strategic guide to using Cyclic Pifithrin-α hydrobromide as a p53 inhibitor for dissecting apoptosis, DNA damage responses, radioprotection, and carefully bounded neuroinflammation hypotheses.
-
S63845: MCL1 Dependence in Dynamic Apoptosis
2026-08-08
S63845 is a selective MCL1 inhibitor for dissecting how mitochondrial apoptosis changes with protein localization, mitotic stress, and GET3 activity. This article connects pharmacological perturbation with state-aware assay design for hematological cancer research.
-
Cleavage-Resistant TREM2 Restores Macrophage Efferocytosis
2026-08-07
Dong et al. report a synthetic cleavage-resistant TREM2 receptor that preserves signaling and enhances macrophage efferocytosis despite inflammatory ADAM17 activity. Phosphatidylserine-functionalized lipid nanoparticles deliver CRT mRNA in situ, reducing apoptotic-cell accumulation and inflammation in mouse models of MASH and atherosclerosis.
-
NSAID Cytotoxicity in Canine Osteosarcoma: Mechanistic Insig
2026-08-07
This article reviews a pivotal study evaluating the cytotoxic effects and mechanisms of deracoxib and piroxicam on canine osteosarcoma cell lines. The research demonstrates selective cytotoxicity of deracoxib at intermediate to high concentrations, with limited apoptosis induction, highlighting implications for bone tumor therapy and research translation.
-
Enhanced mCEC Proliferation with 6C Medium Incorporating DAP
2026-08-06
This study introduces a novel serum-free 6C culture medium that extends the proliferative capacity of mouse corneal epithelial cells (mCEC) in vitro and in vivo. By integrating DAPT, a potent γ-secretase inhibitor, among other pathway modulators, the approach suppresses epithelial-mesenchymal transdifferentiation and preserves progenitor cell characteristics, offering significant implications for regenerative ophthalmology.
-
Redefining Mouse Genotyping: Mechanistic Innovation in Trans
2026-08-06
This thought-leadership article explores how the Direct Mouse Genotyping Kit Plus enables breakthroughs in mouse genotyping workflows, accelerating translational research from mechanistic inquiry—such as neuroinflammation and autophagy in SCA3 models—to high-fidelity genetic screening. By integrating evidence from landmark disease studies, workflow benchmarking, and strategic guidance for translational teams, we outline new standards for mouse colony management and experimental rigor.
-
HyperFluor™ 488 Rabbit Anti-Goat IgG: Advancing Quantitative
2026-08-05
Explore how the HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody transforms quantitative immunoassays with Alexa Fluor 488 precision. Gain unique insights into optimizing detection sensitivity and reproducibility for hypoxia research and beyond.
-
Iron-Dependent KDM4D Regulates MSC Quiescence via PI3K-Akt-F
2026-08-05
This study identifies iron-dependent KDM4D demethylase as a central regulator of mesenchymal stem cell (MSC) activation by epigenetically modulating the PI3K-Akt-Foxo1 pathway. The findings clarify how iron deficiency disrupts bone remodeling at the chromatin level, with implications for osteoporosis research and targeted pathway studies.
-
NF-κB/miR-202-5p/HMGB2 Feedback Attenuates Septic AKI
2026-08-04
This study uncovers a protective negative feedback loop involving NF-κB, miR-202-5p, and HMGB2 that limits inflammation and renal injury during sepsis-induced acute kidney injury (AKI). The findings clarify molecular mechanisms of inflammatory amplification in septic AKI and highlight new targets for intervention.
-
Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis
2026-08-04
This study establishes a novel ferroptosis-related gene signature for prognostic prediction in hepatocellular carcinoma (HCC) and experimentally identifies atorvastatin as a potential agent capable of inducing ferroptosis in HCC cells. The findings provide a foundation for both personalized risk stratification and new therapeutic strategies targeting ferroptosis in liver cancer.
8076 records 8/539 page Previous Next First page 上5页 678910 下5页 Last page